⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17772539 | 0.84 | — | — | |
| SCHEMBL16095997 | 0.83 | ARG1 (0.32) | — | |
| SCHEMBL18023102 | 0.78 | — | — | |
| SCHEMBL25868068 | 0.78 | — | — | |
| SCHEMBL1276314 | 0.77 | — | — | |
| SCHEMBL5764842 | 0.77 | — | — | |
| SCHEMBL10000623 | 0.77 | — | — | |
| SCHEMBL15368821 | 0.74 | — | — | |
| SCHEMBL11546838 | 0.74 | — | — | |
| SCHEMBL3365297 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970521-A1 | MIXED INTERNAL DONOR STRUCTURES FOR 1-OLEFIN POLYMERIZATION CATALYSTS | BASF Corporation (US) | 2016-01-20 | — | — | EP | claimed |
| WO-2014149628-A1 | MIXED INTERNAL DONOR STRUCTURES FOR 1-OLEFIN POLYMERIZATION CATALYSTS | BASF CORPORATION (US) | 2014-09-25 | — | — | WO | claimed |
| EP-2429568-B1 | MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS | ENANTA PHARM INC (US) | 2016-08-17 | — | — | EP | disclosed |
| EP-2970521-A1 | MIXED INTERNAL DONOR STRUCTURES FOR 1-OLEFIN POLYMERIZATION CATALYSTS | BASF Corporation (US) | 2016-01-20 | — | — | EP | disclosed |
| WO-2014149628-A1 | MIXED INTERNAL DONOR STRUCTURES FOR 1-OLEFIN POLYMERIZATION CATALYSTS | BASF CORPORATION (US) | 2014-09-25 | — | — | WO | disclosed |
| WO-2010132163-A1 | MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS | ENANTA PHARMACEUTICALS, INC. (US) | 2010-11-18 | — | — | WO | disclosed |
| WO-2009064975-A1 | QUINOXALINE-CONTAINING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS | ENANTA PHARMACEUTICALS, INC. (US) | 2009-05-22 | — | — | WO | disclosed |